7th Training School on Microencapsulation Strasbourg. Februar 2015 Textmasterformat in Mastervorlage eingeben
|
|
- Delilah Pitts
- 6 years ago
- Views:
Transcription
1 7th Training School on Microencapsulation Strasbourg Februar
2 Dr. Anne Ettner, Glatt Pharmaceutical Services 2
3 Overview 1. Introduction 2. Fluid bed equipment 3. Basics of fluid bed Wurster technology 4. Characteristics of Bottom spray processes 5. Formulation and process parameters 6. Case Studies 3
4 1. Introduction: Pharmaceutical Pellets 4
5 1. Introduction: Pharmaceutical Pellets Spherical particles with smooth and uniform surface Particle size range: µm Narrow particle size distribution Layering of active pharmaceutical ingredients and coating (functional) excipients 5
6 1. Introduction: Pharmaceutical Pellets Formulation concepts for modified release preparations Matrix approach uniform and homogenous matrix Membrane approach multi-layer composition 6
7 1. Introduction: Pharmaceutical Pellets Formulation concepts for modified release preparations Coating of pellets required for: - Delayed release preparations - Extended release products - Taste masking 7
8 1. Introduction: Pharmaceutical Pellets Benefits - reduced variability in dosage (low intra- and inter- individual variability) - controlled onset time of drug release - delivery of API to distal sites within GI tract Pellets can be administered as capsules, tablets, sachets and oral suspensions 8
9 1. Introduction: State-of-the-art Pelletization Technologies Extrusion / Spheronization - Multitude of manufacturing steps Multitude of manufacturing equipment (mixing, wet granulation, extrusion, spheronization, drying, sieving, coating) - Particle size > 500 µm - Broad particle size distribution - Mostly particles not totally spherical 9
10 1. Introduction: State-of-the-art Pelletization Technologies Fluid Bed Layering (e.g. Wurster) - Drug layering onto starter material - Could be time consuming process for high drug loaded products - Narrower particle size distribution compared to extrusion/spheronization Direct pelletization: Rotor fluid bed granulator - Broad particle size distribution 10 10
11 1. Introduction: Fluid bed process for pellets manufacturing starting beads (drug layering liquid) coating liquid(s) application of liquid(s) on pellets no losses no agglomerates specified dissolution profile to be achieved 11 11
12 1. Introduction: Fluid bed process for pellets manufacturing Pellet drug layering and coating principle Starting beads + liquid to be processed 12 12
13 1. Introduction: The coating zone principle Spray drying Coalescence of droplets Spray nozzle Core Evaporation of solvent Penetration Contact / spreading 13 13
14 Overview 1. Introduction 2. Fluid bed equipment 3. Characteristics of Bottom spray processes 4. Formulation and process parameters 5. Case Studies 14 14
15 2. Fluid bed equipment: Fluid bed unit in bottom spray configuration Downbed Upbed Spray nozzle position: Bottom-spray ( Wurster ) 15 15
16 2. Fluid bed equipment: Fresh-air system vs. closed-loop system Fresh air system Water based systems Organic solvent based systems Closed-loop system with N 2 inertisation and organic solvent recovery system (SRS) Organic solvent based systems 16 16
17 2. Fluid bed equipment: Fresh-air system vs. closed-loop system Pellet surfaces Organic solution coating Aqueous dispersion (film condensation not completed) 17 17
18 Overview 1. Introduction 2. Fluid bed equipment 3. Characteristics of Bottom spray processes 4. Formulation and process parameters 5. Case Studies 18 18
19 3. Characteristics of Bottom spray processes Wurster partition HS nozzle Inlet air distribution plate HS collar 19 19
20 3. Characteristics of Bottom spray processes Wurster partition HS nozzle Inlet air distribution plate HS collar 20 20
21 3. Characteristics of Bottom spray processes: Inlet air distribution plate The air flow in the upbed zone is most important for the homogenous application of the film. The most feasible configuration is selected for each product quality (particle size of substrate). Downbed zone Upbed zone 21 21
22 3. Characteristics of Bottom spray processes: Inlet air distribution plate Upbed zone Downbed zone Plate type A B C D Inlet air volume in downbed 22 22
23 3. Characteristics of Bottom spray processes Wurster partition HS nozzle Inlet air distribution plate HS collar 23 23
24 3. Characteristics of Bottom spray processes: Wurster Partition h h downbed upbed downbed upbed 24 24
25 3. Characteristics of Bottom spray processes: High Speed ( HS ) nozzle system + Collar HS nozzle HS nozzle + collar 25 25
26 3. Characteristics of Bottom spray processes 26 26
27 Overview 1. Introduction 2. Fluid bed equipment 3. Characteristics of Bottom spray processes 4. Formulation and process parameters 5. Case Studies 27 27
28 4. Formulation and process parameters Formulation specified, no further optimisation possible Inlet air volume temperature and moisture adjustable Product: moisture temperature Atomization air pressure and spray rate adjustable Drying capacity Fluidization pattern Agglomeration or spray drying 28 28
29 4. Formulation and process parameters: hx diagram (Mollier diagram) For understanding the modifications in terms of HUMIDITY in the process air (inlet and outlet) and in the product, you may use the Mollier-Diagram = the psychrometric chart You can read relative and absolute values for: the inlet air humidity conditions and temperature the outlet air humidity conditions and temperature the product humidity conditions and temperature and you can predict the overwetting condition: when the product temperature reaches the 100 % relative humidity curve
30 4. Formulation and process parameters: hx diagram (Mollier diagram) Moisture can be present at different amounts in air, but the air becomes saturated at some point Air cannot contain more moisture than the saturated amount Hot air can contain more moisture than cold air before saturation is reached - air expands when heated The saturation point depends on the temperature of the air At saturation point, the Relative Humidity is 100% and the temperature is said to be the Dew Point % RH values show the % saturation of air at that temperature If the temperature of a sample of air is increased, its relative Humidity will decrease 30 30
31 Temperature [ C] Pellet Layering and Coating Processes 4. Formulation and process parameters: hx diagram (Mollier diagram) relativ humidity [%] The diagram shows the correlation of evaporation capacity relative humidity in exhaust air product temperature / moisture water content x [ g water / kg dry air] 31 31
32 4. Formulation and process parameters: hx diagram (Mollier diagram) Fluid Bed Layering and Coating in moderate climate conditions Ambient air : temperature 10 C relative humidity 40 % What is the dew point of the air? Heated to 55 C for processing, what will the inlet air relative humidity be? Passed through a bed of wet product, what will the product temperature be? 32 32
33 Temperature [ C] Pellet Layering and Coating Processes 4. Formulation and process parameters: hx diagram (Mollier diagram) B A C water content x [ g water / kg dry air] relativ humidity [%] Ambient conditions:10 C 40% rel. humidity: A x = 3 g / kg dry air heating to 55 C inlet inlet air temp.: A-B x = 3 g / kg dry air rel. hum.: 3,5 % by spraying the drug layering or coating liquid: a defined product moisture expressed as product / exhaust air temperature is achieved in the example: product temperature ~ 30 C rel. humidity ~ 45% stable process good product quality 33 33
34 Temperature [ C] Pellet Layering and Coating Processes 4. Formulation and process parameters: hx diagram (Mollier diagram) ! relative humidity [%] but: do not drive too fast!! Process speed is limited by specific qualities of coating formulations (temperature + moisture induced sticking)!! in the too fast example product temperature ~ 23 C rel. humidity ~ 80% catastrophe water content x [ g water / kg dry air]
35 4. Formulation and process parameters: hx diagram (Mollier diagram) Now what about drying in hot and humid summer times? 35 35
36 4. Formulation and process parameters: hx diagram (Mollier diagram) de-humidification by cooling (10 +/- 2 C) de-humidification +/- re-humidification absorption dryer with desiccants in combination with a de-humidifier + re-humidifier 36 36
37 Temperature [ C] Pellet Layering and Coating Processes 4. Formulation and process parameters: hx diagram (Mollier diagram) relativ humidity [%] A Dehumidification of inlet air Ambient conditions: 37 C, 90% rel. hum.: A 30 x = 38 g / kg dry air B Cooling to 6 C inlet air temp.: A-B rel. hum.: 100 % x = 6 g / kg dry air water content x [ g water / kg dry air]
38 4. Formulation and process parameters: hx diagram (Mollier diagram) 6 C / 100 % rh 6 g water/ kg dry air 37 C, 90% rh 38 g water/ kg dry air 38 6 = 32 [g water/kg dry air] 38 38
39 Overview 1. Introduction 2. Fluid bed equipment 3. Characteristics of Bottom spray processes 4. Formulation and process parameters 5. Case Studies 39 39
40 Summary and Conclusion The WURSTER fluid bed technology is a feasible process for highly efficient and reproducible pellet processing. It is a complex, but very logical and comprehensive process technology which provides stable conditions for particle coating (of pellets, micropellets, crystals ). The understanding of potential interactions of fluid bed equipment configuration and processing parameters is a prerequisite in order to achieve stable processes in development and industrial production. Development is ongoing in order to improve efficiency, stability and safety of processes PAT (Process Analytical Technology)
41 Thank you! Dr. Anne Ettner, Pharmacist Qualified Person Glatt GmbH 41 41
DRY COATING : Techniques & Potentials
Water in Food Workshop Lausanne 2004 DRY COATING : Techniques & Potentials E. TEUNOU - E. IVANOVA - D. PONCELET Nantes Département du Génie des Procédés Alimentaire Content Who are we? Importance and Functionality
More informationPROCELL LABSYSTEM. encapsulation. direct pelletization. Glatt. Integrated Process Solutions.
PROCELL LABSYSTEM Spray granulation Agglomeration Coating encapsulation powder layering direct pelletization Glatt. Integrated Process Solutions. I1 mm I I1 mm I micro organisms, spray granulation, ProCell
More informationDow Pharma Solutions. ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.
Dow Pharma Solutions ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient. Improving Productivity Through Innovation ETHOCEL Polymers is the oldest trademarked brand available from The Dow Chemical
More informationWURSTER COATING- PROCESS AND PRODUCT VARIABLES
WURSTER COATING- PROCESS AND PRODUCT VARIABLES Asija Rajesh *, Dhawan Reetika, Asija Sangeeta, Barupal Ashok Maharishi Arvind Institute of Pharmacy, Jaipur, Rajasthan Abstract In 1959 the wurster process
More informationWorkshop: PELLETS AND MICROPELLETS FOR ORAL MULTIPARTICULATE DOSAGE FORMS October 2017
Workshop: PELLETS AND MICROPELLETS FOR ORAL MULTIPARTICULATE DOSAGE FORMS 10-12 October 2017 BACKGROUND More and more pharmaceutical products are reaching the market as multiparticulate dosage forms, mainly
More informationARIA FLUID BED PROCESSOR
ARIA FLUID BED PROCESSOR ARIA Precise parameter control and premium quality engineering are the key features of IMA Active division s fluid bed processor. Simplified processing concepts based on smart
More informationAnhydro Drying Systems FOR THE PHARMACEUTICAL INDUSTRY
Anhydro Drying Systems FOR THE PHARMACEUTICAL INDUSTRY SPX Flow Technology Danmark A/S is an international engineering company with a consistent goal to provide our customers with the optimal processing
More informationImplementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development. S Betterman 15Apr2015
Implementing Quality by Design Principles and Concepts to Drug Delivery and Formulation Development S Betterman 15Apr2015 Agenda Background Implementation Strategy Infrastructure Building Project Application
More informationMaximizing Roller Compaction Benefits with Proper Excipient Selection
A sponsored whitepaper. Maximizing Roller Compaction Benefits with Proper Excipient Selection By: Bernhard Fussnegger, Global Development and Technical Marketing, PVP/Coatings, Instant & Modified Release,
More informationMETHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow
METHOCEL Cellulose Ethers A product that can do it all TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow The possibilities are endless Pharmaceutical companies are continuously
More informationSoluplus. Technical Information. October _090801e-01/Page 1 of 8. = Registered trademark of BASF group. Pharma Ingredients & Services
Technical Information Soluplus October 2009 03_090801e-01/Page 1 of 8 = Registered trademark of BASF group Pharma Ingredients & Services 03_090801e-01 October 2009 Page 2 of 8 Soluplus 1. Introduction
More informationLegal Notice copyright 2015 Romaco Innojet GmbH
Legal Notice copyright 2015 Romaco Innojet GmbH This complete presentation is property of Romaco Innojet GmbH in D-Steinen. Publishing in any media neither of the total document nor of parts of it like
More informationDevelopment of paediatric formulations - points to consider
Development of paediatric formulations - points to consider Workshop on Paediatric Formulations II London, 8 November 2011 Presented by: Ann Marie Kaukonen Scientific Administrator, Paediatric Medicines,
More informationIndian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)
Fluidized bed processing: A review Ravi Teja Pusapati*, T. Venkateswara Rao Bapatla College of Pharmacy, Bapatla-522101, Guntur (district), Andhra Pradesh, India. *Corresponding author: E.Mail: raviteja.pusapati@gmail.com
More informationSUSTAINED RELEASE From Coated Ion Exchange Resins. H.S. Hall Coating Place, Inc. Verona, WI 53593
SUSTAINED RELEASE From Coated Ion Exchange Resins 79-1 by H.S. Hall Coating Place, Inc. Verona, WI 53593 A substantial amount of work has been published concerning the use of ion exchange resins for sustained
More informationQbD implementation in Generic Industry: Overview and Case-Study
QbD implementation in Generic Industry: Overview and Case-Study Inna Ben-Anat, QbD Strategy Leader, Teva Pharmaceuticals IFPAC JAN 2013 R&D Three Core Components of QbD and Generic Industry: How Do They
More informationPLANKSTADT EXPERTS TAKING CARE
CordenPharma PLANKSTADT EXPERTS TAKING CARE Our History 1977 - Start of Packaging activities (ICI Pharma) 1980 - Start of Formulation activities (ICI Pharma) 1995 - First Pre-approval Inspection by FDA
More informationSeamless Integration of a Semi- Continuous Coating Process into Existing Solid Dosage Production
Seamless Integration of a Semi- Continuous Coating Process into Existing Solid Dosage Production Abstract A study was conducted using the KOCO 25 in conjunction with the ROB 50, in order to provide insight
More informationAvailable online through ISSN
Review Article Available online through www.ijrap.net ISSN 2229-3566 MULTIPLE UNIT DOSAGE FORM - PELLET AND PELLETIZATION TECHNIQUES: AN OVERVIEW Kumar Vikash*, Mishra Santosh Kumar, Lather Amit, Vikas,
More informationPhotolithography I ( Part 2 )
1 Photolithography I ( Part 2 ) Chapter 13 : Semiconductor Manufacturing Technology by M. Quirk & J. Serda Bjørn-Ove Fimland, Department of Electronics and Telecommunication, Norwegian University of Science
More informationPHARMACEUTICAL MANUFACTURING
PHARMACEUTICAL MANUFACTURING WHAT IS PHARMACEUTICAL MANUFACTURING IT IS THE PROCESS OF INDUSTRIAL SCALE SYNTHESIS OF PHARMACEUTICAL DRUG BY PHARMACEUTICAL COMPANIES. THE PROCESS CAN BE BROKEN DOWN INTO
More informationPelletization Techniques: A Review
ABSTRACT: Pelletization is an agglomeration process that converts fine powders or granules of bulk drugs and excipients into small, free flowing, spherical or semi-spherical units, referred to as pellets.
More informationOn-Demand Manufacturing of Pharmaceuticals
On-Demand Manufacturing of Pharmaceuticals Innovation in continuous filtration, drying and formulation of drugs International Symposium on Continuous Manufacturing of Pharmaceuticals Salvatore Mascia Sep
More informationMicrocrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate
Microcrystalline Cellulose, Colloidal Silicon Dioxide, Sodium Starch Glycolate, Sodium Stearyl Fumarate Ready-to-Use High Functionality Excipient Composite Offering Advantages for Total Cost Savings Superior
More informationBalancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL
Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels
More informationPharma Ingredients & Services. Ludiflash. Technical Information
Technical Information Ludiflash March 2012 Supersedes issue dated August 2011 03_070805e-03/Page 1 of 10 = Registered trademark of BASF group Excipient for fast-disintegrating oral dosage forms Direct
More informationPharma & Food Solutions. ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications
Pharma & Food Solutions ETHOCEL One of the Few Water-Insoluble Polymers Approved for Global Pharmaceutical Applications ETHOCEL Premium Polymers are essentially tasteless, colorless, odorless, noncaloric
More informationApproaches to the formulation of poorly soluble drugs
1 Approaches to the formulation of poorly soluble drugs R. Christian Moreton, Ph.D FinnBrit Consulting ExcipientFest 2013, April 30 May 01, 2013, Baltimore, MD 2 Disclaimer The views expressed in this
More informationINTERPHEX USA 80-1 ROUTINE EVALUATION OF FILM COATING PROCESSES. M. Talei, Pharm.D., Ph.D. ALZA Corporation Palo Alto, CA INTRODUCTION
80-1 INTERPHEX USA ROUTINE EVALUATION OF FILM COATING PROCESSES M. Talei, Pharm.D., Ph.D. ALZA Corporation Palo Alto, CA 94304 1 INTRODUCTION Film coating of solid dosage forms has been carried out in
More informationRoller compactors for the pharmaceutical industry. BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma
Roller compactors for the pharmaceutical industry BT 120 Pharma WP 120 Pharma WP 150 Pharma WP 200 Pharma Roller compactors for the pharmaceutical industry Compaction and granulation in the pharmaceutical
More informationTHE INFLUENCE OF THE MOISTURE CONTENT OF MICROCRYSTALLINE CELLULOSE ON THE COATING PROCESS IN A FLUIDIZED BED
Brazilian Journal of Chemical Engineering ISSN 0104-6632 Printed in Brazil Vol. 21, No. 02 pp. 325-333, April - June 2004 THE INFLUENCE OF THE MOISTURE CONTENT OF MICROCRYSTALLINE CELLULOSE ON THE COATING
More informationInt. J. Pharm. Sci. Rev. Res., 34(1), September October 2015; Article No. 23, Pages: Process Validation of Tablet Dosage Form in Industries
Review Article Process Validation of Tablet Dosage Form in Industries Ram Mohan S.R, N. Vishal Gupta* Pharmaceutical Quality Assurance group, Dept of Pharmaceutics, JSS University, Sri ShivarathreeshwaraNagara,
More informationHow to Identify Critical Quality Attributes and Critical Process Parameters
How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,
More informationOutline. Opportunities Overview of ASAP Areas of Application ASAP Proposal to Regulators Summary
Outline Opportunities Overview of ASAP Areas of Application ASAP Proposal to Regulators Summary Opportunities n Provide cost benefits and possible alternate methods for demonstrating product stability
More informationExperimental Validation of Macro- and Micro-Level Scaling Laws in Small- and Medium-Scale Top-Spray Fluidised Bed Coaters
Refereed Proceedings The 12th International Conference on Fluidization - New Horizons in Fluidization Engineering Engineering Conferences International Year 2007 Experimental Validation of Macro- and Micro-Level
More informationWHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability
2017 WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability Eric C Buxton Clinical Associate Professor University of Wisconsin Madison School of Pharmacy, Division of Pharmacy
More information* Current monograph name valid until May 1, 2017 ** New monograph name valid as of May 1, 2012, mandatory as of May 1, 2017
Technical Information EUDRAGIT L 30 D-55 Specification and Test Methods Ph. Eur. Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Dispersion 30 Per Cent USP/NF Methacrylic Acid Copolymer Dispersion -
More informationNovel Floating Pulsatile Approach for Chronotherapeutic Release of Indomethacin
Novel Floating Pulsatile Approach for Chronotherapeutic Release of Indomethacin Shaji Jessy and Patole Vishal Prin. K. M. Kundnani College of Pharmacy, 23, Jote Joy Bldg., Rambhau Salgaonkar Marg, Colaba,
More informationChapter 6. Multiphase Systems. Dr. M. A. A. Shoukat Choudhury Website:
Chapter 6 Multiphase Systems Dr. M. A. A. Shoukat Choudhury Email: shoukat@buet.ac.bd Website: http://teacher.buet.ac.bd/shoukat/ Multiphase Systems Why Study? - Phase change operations such as freezing,
More informationCharacteristics of Solder Paste
Characteristics of Solder Paste Flow Solder paste is a viscous non-newtonian fluid, whose resistance to flow is not constant, and which exhibits shear thinning. This is an essential requirement for printing,
More informationKollidon The Original Setting new standards in stability, purity and patient safety.
Kollidon The Original Setting new standards in stability, purity and patient safety. Now with new PeroXeal packaging Bernhard Fussnegger, an enabler in excipients Pharma Ingredients & Services. Welcome
More informationTestosterone 20 mg Oral Rapid-Dissolve Tablets (Solid Suspension, 96 x 750 mg [0.93 ml] Tablets) Ingredient Listing Qty. Unit NDC # Supplier
4/16/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Testosterone (Micronized), USP 1.920 g Orange Flavor (Powder) 0.40 g Vanillin Flavor (Powder) 0.20 g Stevia Powder (Stevioside)
More informationART User Guide. Solid particles that are formed by aerosolization of already existing powders or by abrasion of solid objects.
ART User Guide Introduction ART is a free web-based tool for the estimation of inhalation exposure at the workplace. ART combines a mechanistic model and a facility to update the estimates with the user
More informationSIZE REDUCTION TECHNOLOGY
SIZE REDUCTION TECHNOLOGY HOSOKAWA Alpine Size Reduction Technology Process Solutions for Granulation Requirements Alpine offers a variety of techniques tailored to meet the requirements of your business.
More informationHigh efficient peak power on demand. Answers for energy.
www.siemens.com/energy High efficient peak power on demand POWER-GEN Asia 2011 KLCC, Malaysia, Kuala Lumpur September 27 29, 2011 Authors: Jan Dirk Beiler Siemens AG Energy Sector Fossil Power Generation
More informationPharma Ingredients & Services. Soluplus. Technical Information. = Registered trademark of BASF group. July 2010 Supersedes issue dated May 2010
Technical Information Soluplus July 21 Supersedes issue dated May 21 3_981e-4/Page 1 of 8 = Registered trademark of BASF group Pharma Ingredients & Services 3_981e-4 July 21 Page 2 of 8 Soluplus 1. Introduction
More informationOSDrC OptiDose : A Revolution in Drug Formulation Technology
Review Article OSDrC OptiDose : A Revolution in Drug Formulation Technology Sayantany Chandra*, Sayantan Sadhukhan, Sabyasachi Maiti, Somasree Ray Department of Pharmaceutics, Gupta College of Technological
More informationStatistical Design Space Development from Design of Experiment to granules Expert of Solids Certification Seminar March 11 to 12, 2014
Statistical Design Space Development from Design of Experiment to granules Expert of Solids Certification Seminar March 11 to 12, 2014 Expert of Solids and Master of Solids certificated by Hüttlin GmbH
More informationMeeting Solid Dose Formulation Challenges
Streamlining (Fast Tracking) Solid Dosage Form Development Tony Carpanzano, B.S., R. Ph. Director, Research & Development Streamlining (Fast Tracking) Solid Dosage Form Development Meeting Solid Dose Formulation
More informationPreface... iii Contents...vii Contributors...xv. 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion...
Contents Preface... iii Contents...vii Contributors...xv 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion... 1 1 Background... 1 1.1 Introduction... 1 1.1.1
More informationGUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS
GUIDE TO INSPECTIONS OF STERILE DRUG SUBSTANCE MANUFACTURERS Note: This document is reference material for investigators and other FDA personnel. The document does not bind FDA, and does no confer any
More informationFigure 1. Standard spray congealing setup.
Conrad Winters Spray congealing: applications in the Pharmaceutical Industry PAULA CORDEIRO, MÁRCIO TEMTEM, CONRAD WINTERS* *Corresponding author Hovione, R&D, Drug Product Development Group, Sete Casas,
More informationDesign and Dosage Form. Dr. Deny Susanti
Design and Dosage Form Dr. Deny Susanti Example 1 Aspirin tablet is stable but not as a liquid dosage form How to design liquid form? Soluble or dispersible aspirin tablets-to be dissolved in water Note:
More informationCaffeine 100 mg, Scopolamine Hydrobromide 0.5 mg Oral Rapid-Dissolve Tablets (Solid Suspension, 96 x 750 mg [0.93 ml] Tablets)
4/19/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Caffeine (Anhydrous), USP 9.600 g Scopolamine Hydrobromide, USP 0.050 g Mango Flavor (Powder) 0.75 g Raspberry Flavor
More informationEMCOMPRESS. Calcium Hydrogen Phosphate, Ph.Eur., E 341(ii) Dibasic Calcium Phosphate, USP/NF, FCC. A Proven Excipient for more than 60 Years
EMCOMPRESS Calcium Hydrogen Phosphate, Ph.Eur., E 31(ii) Dibasic Calcium Phosphate, USP/NF, FCC A Proven Excipient for more than 60 Years Functional Filler Flow Enhancer for High Speed Tableting Calcium
More informationBasic Aspects of Process Validation of Solid Oral Dosage Forms
Review Article Basic Aspects of Process Validation of Solid Oral Dosage Forms Sharma Tejal Department of Pharmaceutics, B. N. Girls College of Pharmacy, Udaipur (Raj.) 313002(India) Validation of the manufacturing
More informationApplication of Quality by Design (QbD) in product development. James E. Polli September 16, 2015
Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route
More informationPowder flow What and how to measure. Gabrie Meesters
2 Powder flow What and how to measure Gabrie Meesters Flowability according to Carr Flowability-fluidity Angle of repose : α R Compressibility: C Angle of spatula : α S Cohesiveness: Co 2 Angle of repose
More informationFRAUNHOFER INSTITUTE FOR CERAMIC TECHNOLOGIES AND SYSTEMS IKTS CENTER OF COMPETENCE POWDER TECHNOLOGY
FRAUNHOFER INSTITUTE FOR CERAMIC TECHNOLOGIES AND SYSTEMS IKTS CENTER OF COMPETENCE POWDER TECHNOLOGY PRODUCT DESIGN READY-TO-PRESS-POWDER (PREMIX) POWDER FOR THERMAL CLADDING AND SPRAYING FUNCTIONAL POWDERS
More informationPractical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up
Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up Editor: Mohammed Maniruzzaman (C(%SM1THERS R A P R A A Smithers Group Company Shawbury, Shrewsbury, Shropshire, SY4 4NR, United
More informationGUIDELINE FOR THE STABILITY TESTING
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 GUIDELINE FOR THE STABILITY TESTING OF NON-PRESCRIPTION (OTC)
More informationTechnical brochure FlowLac
L W TABLETING DIRECT COMPRESSION SPRAY-DRIED LACTOSE AC Technical brochure FlowLac MEGGLE spray-dried lactose grades for direct compression: FlowLac General information Direct compression (DC) tablet manufacture
More informationExcipient Development at NCL
New Reverse Enteric Polymer for Oral Dosage Forms Excipient Development at omplete Solution for Taste Masking Moisture Barrier Sustained Release Immediate Release Polymorphism Inhibition National hemical
More informationMicrobiological Consideration for Non-Sterile Pharmaceutical
May 1-3, 2012 Javits Center New York, NY Microbiological Consideration for Non-Sterile Pharmaceutical Dr. Leonard W. Mestrandrea Principal Consultant MESTRANDREA CONSULTING LLC Title Date Microbial Control
More informationReal-time tablet API analysis: a comparison of a palm-size NIR spectrometer to HPLC method
Real-time tablet API analysis: a comparison of a palm-size NIR spectrometer to HPLC method Presented by: Chris Pederson, Product Applications Engineer, JDS Uniphase Corp. Co-Authors: Nada O Brien, JDS
More informationOptimizing Spray Performance with Computational Fluid Dynamics. From Spraying Systems Co. Spray Analysis. Spray Control.
From ing Systems Co. Optimizing Performance with Computational Fluid Dynamics Nozzles Control Analysis Fabrication Using Computational Fluid Dynamics (CFD) CFD is the science of predicting: Fluid flow
More informationESFUELCELL MAXIMIZING THE USE OF PLATINUM CATALYST BY ULTRASONIC SPRAY APPLICATION
PROCEEDINGS OF ASME 2011 5TH INTERNATIONAL CONFERENCE ON ENERGY SUSTAINABILITY & 9TH FUEL CELL SCIENCE, ENGINEERING AND TECHNOLOGY CONFERENCE ESFUELCELL2011 AUGUST 7-10, 2011, WASHINGTON, DC, USA ESFUELCELL2011-54369
More informationIdentification of CPPs based on CQAs & Mechanistic Process & Product Understanding: A Case Study
Identification of CPPs based on CQAs & Mechanistic Process & Product Understanding: A Case Study Ajit S. Narang, Ph.D. Bristol-Myers Squibb, Co. 2 nd FDA/PQRI Conference on Advancing Product Quality Bethesda,
More informationFormulation Development
Quality by Design and Formulation Development WF Busch Senior Application Development Specialist Dow Chemical Company IPEC Americas, Quality by Design Committee 5 May 2010 Disclaimer The views and opinions
More informationPharmaceutical Sciences
SRI International Biosciences From Idea to IND Research on Disease Mechanisms Drug Discovery Drug Metabolism, Pharmacokinetics, & Toxicology Services Pharmaceutical Sciences Preclinical Development Planning
More informationCHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE
CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE Paul Stott, PhD Head of US Product Development AstraZeneca ICH Quality Guidelines Workshop BioKorea 2007 Sept 13-14
More informationANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS
Association of South East Asian Nations (ASEAN) ANNEX V ASEAN GUIDELINES ON STABILITY STUDY AND SHELF-LIFE OF HEALTH SUPPLEMENTS Disclaimer: This document is provided for information purpose only and subject
More informationPARAMETRIC STUDY OF COATING BY COOLING CRYSTALLIZATION
Third International Conference on Energy, Materials, Applied Energetics and Pollution. ICEMAEP2016, October 30-31, 2016, Constantine,Algeria. PARAMETRIC STUDY OF COATING BY COOLING CRYSTALLIZATION Fatima
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article PELLETIZATION TECHNIQUES: A LITERATURE REVIEW Punia Supriya* 1, Bala Rajni 1, Rana A.C. 2 1 Department of Pharmaceutics,
More informationDepartment of Pharmaceutics, JSS College of Pharmacy, (A Constituent College of JSS University, Mysore), Ooty, The Nilgiris, Tamil Nadu, India
IJPSR (2011), Vol. 2, Issue 6 (Review Article) Received on 08 March, 2011; received in revised form 20 April, 2011; accepted 16 May, 2011 PELLETIZATION TECHNOLOGY: A QUICK REVIEW Kammili Lavanya*, V. Senthil
More informationRapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products
RapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products Kevin Kane, Scientific Director, BCP 7 th Annual Global Drug Delivery & Formulation Summit 28 th August
More informationRoller Compaction: New trends, challenges and solutions
Roller Compaction: New trends, challenges and solutions TODD STUTZMAN, PHARM.D. R.PH. DIRECTOR, PHARMACEUTICS SARAH PYSZCZYNSKI, PH.D. PRINCIPAL SCIENTIST 21FEB2017 2017 Catalent Pharma Solutions. All
More informationSolid Phase transformation considerations during process development and manufacture of solid oral dosage forms A Review
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.6, No.7, pp 1963-1969, November 2014 Solid Phase transformation considerations during process development and manufacture
More informationExperimental Study of Humidification-Dehumidification (HDH) Seawater Desalination Driven by Solar Energy
Experimental Study of Humidification-Dehumidification (HDH) Seawater Desalination Driven by Solar Energy Problem and Research Objectives Desalination produces freshwater by removing dissolved minerals
More informationInternational Journal of Research and Reviews in Pharmacy and Applied science.
International Journal of Research and Reviews in Pharmacy and Applied science www.ijrrpas.com Rakesh Kumar sharma Department of Pharmaceutics, College of Pharmacy, King Saud bin Abdulaziz University for
More informationFluidized bed spray granulation Directly from liquid to granules
Directly from liquid to granules www.andritz.com Experience makes the difference ANDRITZ SEPARATION was among the first to introduce fluidized bed technology for use in industrial drying. We have been
More informationR&D TO PRODUCT: HOW TO REDUCE COSTLY SCALE-UP PROBLEMS
WHITEPAPER R&D TO PRODUCT: HOW TO REDUCE COSTLY SCALE-UP PROBLEMS { When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect
More informationPat Monitoring of Particles in API Manufacture and Formulation
Pat Monitoring of Particles in API Manufacture and Formulation By: Brian O Sullivan Ph.D PAT Seminar Singapore Sept 11 th 2007 brian.osullivan@mt.com What do these have in common? Space shuttle Lipitor
More informationPerformance Testing of Novel Dosage Forms
RQA Ireland Regional Forum - Athlone, May 2016 Quality Considerations Pharma and Biopharma Performance Testing of Novel Dosage Forms Terry Way BPharm MAPS Dissolution Science Consultant Glasside Technologies
More informationValidation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges
Validation Guide USTR 2114 (2) Validation Guide for Pall Emflon PFR Filter Cartridges CONTENTS Part I. Overview 4 1. Introduction 4 2. Summary of Conclusions 4 Part II. Studies on Removal Efficiency 6
More informationPHEN 612 SPRING 2008 WEEK 13 LAURENT SIMON
PHEN 612 SPRING 2008 WEEK 13 LAURENT SIMON Crystallization Crystallization is a common separation process in Commodity inorganic industry (e.g., salts) Food industry (e.g., sugars) Pharmaceutical manufacturing
More informationRegulatory Assessment
Implementation of ICH Q8, Q9, Q10 Regulatory Assessment International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Presentation Overview Goal
More informationFunctionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients
Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients ExcipientFest Americas, San Juan, PR April 29 th 2015 Dr. Carolina Diaz Quijano_ carolina.diazquijano@omya.com
More informationPlant Utilities and Energy Efficiency CH505
Plant Utilities and Energy Efficiency CH505 Teaching Scheme Course code CH505 Course Name Plant Utilities and Energy Efficiency Teaching scheme L T P Credit 3 0 0 3 Process Process is simply a method by
More informationExamples of key binding elements in the PIP decisions
16 December 2013 EMA/174403/2013 Human Medicines Development and Evaluation 7 Westferry Circus Canary Wharf London E14 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7040 E-mail
More informationScientific and Regulatory challenges in Quality by Design (QbD) submissions
Health Santé Canada Canada Scientific and Regulatory challenges in Quality by Design (QbD) submissions Krishnan R. Tirunellai, Ph. D. Bureau of Pharmaceutical Sciences TPD, Health Canada CVG, October 2007
More informationTASTE-MASKING - Pharmaceutical Taste-Masking Technologies
Share this story: Issue: July/August 2015, Posted Date: 6/30/2015 TASTE-MASKING - Pharmaceutical Taste-Masking Technologies INTRODUCTION Taste-masking techniques are applied to mask or overcome the bitter
More informationFilm Coating Process Considerations for the Application of High Productivity, High Solids Concentration Film Coating Formulations
Opadry II Application Data High Productivity Film Coating System Film Coating Process Considerations for the Application of High Productivity, High Solids Concentration Film Coating Formulations PURPOSE
More informationExperimental design on product development
Experimental design on product development Introduction What is the traditional developing method? What is experimental design? What do we need and what kind of possibilities do we have for designing?
More informationKollidon SR: A polyvinyl acetate based excipient for DCsustained-release
Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release oral dosage forms by Dr. Bernhard Fussnegger BASF Aktiengesellschaft, Ludwigshafen Strategic Marketing Pharma Excipients Introduction
More informationSYMPOSIUM ON INDUSTRIAL APPLICATIONS OF GAS TURBINES
20TH SYMPOSIUM ON INDUSTRIAL APPLICATIONS OF GAS TURBINES Inlet Fogging and Overspray Impact on Gas Turbine Life and Performance by Klaus Brun / Southwest Research Institute Rainer Kurz / Solar Turbines
More informationMATHEMATICAL MODELING OF DRYING KINETICS OF CORN IN ELECTRON FIRED FLUIDIZED BED DRYER
International Journal of Mechanical Engineering and Technology (IJMET) Volume 8, Issue 6, June 2017, pp. 51 58, Article ID: IJMET_08_06_006 Available online at http://www.iaeme.com/ijmet/issues.asp?jtype=ijmet&vtype=8&itype=6
More informationSuccessful Introduction of PAT Requires a Strategy
OR AL SOLID DOSAGE CONTINUOUS MANUFACTURING TECHNOLOGIE S Successful Introduction of PAT Requires a Strategy By Dr. Hubertus Rehbaum, Pharma/Life Sciences Consultant F Dr. Hubertus Rehbaum or the past
More informationAbcite 585 EF. Technical Data and Application Guide. Product description. Typical applications. Product range. Product certifications.
Product description is a single layer, primer-free, halogen-free, high strength adhesive thermoplastic powder coating which provides shattering protection for glass pieces and preserves the original glass
More informationPreparative, Pilot & Process Columns
Preparative, Pilot & Process Columns 321 Preparative, Pilot & Process Columns Contents Prep Columns... 322-323 Dynamic Axial Compression Columns (DAC)... 324-325 Pilot Columns... 326-327 Chromatography
More information